Health and Medicine

(iStock)
October 26, 2017

Study to test combination therapy for breast cancer

Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

By VUMC News and Communications
Tuya Pal, associate professor of medicine and Ingram Associate Professor of Cancer Research (Daniel Dubois/Vanderbilt)
October 26, 2017

New faculty: Tuya Pal, associate professor of medicine and Ingram Associate Professor of Cancer Research

A high school science class discussion about how genetic traits are passed down from one generation to another inspired Tuya Pal to pursue a career in clinical genetics. Pal is a physician who specializes in cancer health disparities among diverse populations.

By VUMC News and Communications
October 19, 2017

Forum highlights strong clinical, translational research efforts

Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.

By Bill Snyder
October 18, 2017

Calcium intake and colorectal cancer

Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered.

By Leigh MacMillan
October 16, 2017

Gender, pain and dementia

Understanding sex differences in pain perception could lead to more targeted and effective pain assessment and management strategies in older adults with Alzheimer’s disease.

By Bill Snyder
October 16, 2017

New faculty: Mariann Piano, professor of nursing and senior associate dean for research

Four to five drinks in an evening. Starting the weekend on Thursday with happy hour. No big deal, right? Wrong, according to Mariann Piano, whose work indicates that binge drinking by young adults 18-30 may lead to vascular dysfunction and increased vulnerability to cardiovascular disease.

By VUMC News and Communications
October 13, 2017

New tools to combat kidney fibrosis

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.
By Leigh MacMillan
October 12, 2017

A switch for autoimmunity

Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies.
By VUMC News and Communications
October 12, 2017

Researcher targets peanut allergies with Cohen Fund support

Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment.
By Leigh MacMillan
October 12, 2017

VIGH receives federal grants to fight kidney disease

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.
By Bill Snyder
October 5, 2017

Major international study testing therapy to prevent spread of HIV

Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus).
By Bill Snyder
October 5, 2017

Mayor to speak at Center for Addiction Research science day

Nashville Mayor Megan Barry will speak during a “science day,” Tuesday, Oct. 17, at the Belcourt Theatre hosted by the Vanderbilt Center for Addiction Research (VCAR).
By Bill Snyder
October 4, 2017

Boosting sarcoma cell death

A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.
By Leigh MacMillan
1 … 80 81 82 83 84 … 197